We are a medical device company.
Our biotech device, BioPan, which is a true artificial pancreas -- not a pump and glucose monitor -- allows diabetics to lead a life of pre-diabetes. No constant self testing and injecting insulin.
Our alternate exit strategies are to partner or license the device at select milestone stages and/or to form aliiance(s) with existing major players in the diabetic field to market the product.